Subscribe

245 - Biogen

Jay Fram

The biotechnology company discovers and manufactures treatments for autoimmune disorders, neurodegenerative diseases, and hemophilia. It also makes and sells biosimilars of advanced biologics.

Key Metrics & Financials (Last Fiscal Year)

Previous Rank248
Revenues ($M)$12274
Revenue Percent Change7.2%
Profits ($M)$2539.1
Profits Percent Change-31.4%
Assets ($M)$23653
Market Value — as of March 29, 2018 ($M)$57930
Employees7300

More from FORTUNE

Company Facts

Employees7300
SectorHealth Care
IndustryPharmaceuticals
HQ LocationCambridge, Mass.
CEOMichel Vounatsos
CEO Title-
Websitewww.biogen.com
Years on Fortune 500 List9

See Full List

Outbrain

More from FORTUNE